As of 4:00pm ET
| -0.07 / -0.87%|
The 8 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 24.00 and a low estimate of 6.00. The median estimate represents a +114.11% increase from the last price of 7.94.
The current consensus among 8 polled investment analysts is to Buy stock in Bellicum Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.